Interaction Checker
No Interaction Expected
Emtricitabine/Tenofovir-DF (FTC/TDF, PrEP)
_ZZStavudine (d4T)
Quality of Evidence: Very Low
Summary:
Coadministration with the emtricitabine/tenofovir-DF has not been studied. No significant interaction was observed following administration of emtricitabine alone (200 mg single dose) and stavudine (40 mg single dose) to 6 HIV-negative subjects. Similarly, no significant interaction was observed following administration of a single dose of the extended release formulation of stavudine (d4T-XR 100 mg) and tenofovir-DF (300 mg once daily). No dose modification is required.
Description:
View all available interactions with Emtricitabine/Tenofovir-DF (FTC/TDF, PrEP) by clicking here.
No Version Present
Copyright © 2024 The University of Liverpool. All rights reserved.